Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Janssen Pilot Speeds Up African Approvals As Harmonization Project Expands

Executive Summary

A recent pilot involving Janssen Pharmaceutica has shown that drug approval times were reduced from a median of 20 months to seven months in a set of sub-Saharan African countries using a new “collaborative registration procedure” as part of the African Medicines Regulatory Harmonization initiative. In part 2 of this article on the AMRH, we look at the results of the pilot, how the initiative is being expanded to include more countries and to cover clinical trials and pharmacovigilance, and how far efforts to set up an African Medicines Agency by 2018 might bear fruit.


Related Content

Could The EMA Be A Regulatory Model For East Africa?
WHO Steps Up Plan For Speeding Drug Approvals In Resource-Poor Countries
African Regulatory Harmonization Project Cuts Drug Approval Times And Saves Scarce Resources


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts